IRLAB Therapeutics Email Formats

Biotechnology Research • Gothenburg, Västra Götaland County, Sweden • 21-50 Employees

IRLAB Therapeutics Email Formats

IRLAB Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@irlab.se), used 53.3% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@irlab.se	53.3%
{first initial}.{last name}	j.doe@irlab.se	46.7%

Key Contacts at IRLAB Therapeutics

Christer Nordstedt

Member Board Of Directors

Kristina Torfgå

Chief Executive Officer

Fredrik Hansson

Director Clinical Science & Biometrics

Johanna Landström

Director Clinical Operations & Quality

Hans-Olov Olsson

Member Board Of Directors

Company overview

Headquarters	Arvid Wallgrens Backe 20, Göteborg, 41346, SE
Phone number	+46317573800
Website	irlab.se
NAICS	541714
SIC	283
Founded	2013
Employees	21-50
Socials

About IRLAB Therapeutics

IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company's most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in Phase IIb and are designed to treat some of the most difficult symptoms related to Parkinson's . In 2021, Ipsen, a specialty pharma company, acquired exclusive global rights to the development and commercialization of mesdopetam. IRLAB has discovered and generated all its drug candidates and continues to discover innovative drug candidates for the treatment of CNS disorders through its proprietary systems biology-based Integrative Screening Process (ISP) research platform. In addition to IRLAB’s strong clinical pipeline, the company is also progressing two preclinical programs, IRL942 and IRL757, towards Phase I studies. IRLAB is listed on Nasdaq Stockholm. More information on www.irlab.se.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Director

Employees by Department

IRLAB Therapeutics has 19 employees across 6 departments.

Departments

Number of employees

Funding Data

Explore IRLAB Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2018-12-01	9	$81,400
2024-01-21	9	$2,000,000
2025-08-18	14	$12,000,000

Funding Insights

$14,081,400

Total funding amount

$12,000,000

Most recent funding amount

Number of funding rounds

IRLAB Therapeutics Tech Stack

Discover the technologies and tools that power IRLAB Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Maps

Maps

Microsoft 365

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

WPML

Translation

Linkedin Insight Tag

Analytics

Yoast SEO

SEO

Google Tag Manager

Tag managers

Linkedin Ads

Advertising

Frequently asked questions

IRLAB Therapeutics is located in Gothenburg, Västra Götaland County, SE.

You can reach IRLAB Therapeutics at +46317573800.

IRLAB Therapeutics was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

IRLAB Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

IRLAB Therapeutics has raised a total of $14,081,400 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at IRLAB Therapeutics

Christer Nordstedt

Member Board Of Directors

Kristina Torfgå

Chief Executive Officer

Fredrik Hansson

Director Clinical Science & Biometrics

Johanna Landström

Director Clinical Operations & Quality

Hans-Olov Olsson

Member Board Of Directors

4.8